Series A Therapeutics Companies

InHandPlus is developing solutions to improve the way we take our prescribed medications.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Upkara operates as a biotechnology company that specializes in developing biopreservation technologies.

SpectrumAi is modernizing and democratizing access to high-quality autism treatment.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Switch Therapeutics is a biotech company that develops RNAi therapies.

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.